Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-12-01T04:44:25.528Z Has data issue: false hasContentIssue false
  • English
  • Français

Optimal length of continuation therapy: A prospective assessment during fluoxetine long-term treatment of major depressive disorder

Published online by Cambridge University Press:  16 April 2020

D. Michelson ,
M. Wilson ,
K. Sundell  and
C. Beasley
D. Michelson
Affiliation:
Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA
M. Wilson
Affiliation:
Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA
K. Sundell
Affiliation:
Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA
C. Beasley
Affiliation:
Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Symposia
Information
European Psychiatry , Volume 13 , Issue S4: Standards of psychiatry - 9th Congress of Association of European Psychiatrists , 1998 , pp. 268s
Copyright
Copyright © European Psychiatric Association 1998
Submit a response

Comments

No Comments have been published for this article.